Krakamp B, Leidig P, Gehmlich D, Paul A
Medizinische Klinik I, Kliniken der Stadt Köln, Krankenhaus Merheim.
Zentralbl Chir. 1997;122(5):349-56; discussion 356-7.
Overweight and extreme morbid obesity are a common problem in our society. There are many therapeutic options currently available, but none of them can be considered as being ideal. One of these therapeutic interventions is the implantation of an intragastric balloon under endoscopic guidance.
Investigation of the effect of intragastric balloon Implantation on weight reduction.
In a prospective (and in part blinded) study 4 groups of patients (n = 10 each) were evaluated. In group I and II an intragastric balloon was implanted under endoscopic guidance. Group II had an intensive additional therapy by a dietition. Group I was advised to restrict themselves to a 1500 kcal diet. Group III did receive a sham implantation and the same additional therapy as group II. Group IV served as a control group and did not receive any type of treatment except the advice to restrict themselves to a diet. All balloons were explanted after 6 months. The overall follow-up rate was 18 months with a regular control of patients body weight.
Patient inclusion criteria were comparable in all 4 groups. After 6 and 12 months a marked weight reduction was observed in group I and II when compared with group III and IV. This weight reduction was stable over time and reached statistical significance after 18 months. Additionally the results of group II (intensive additional therapy by a dietition) were better than in group I. Patients of group IV gained weight. No major complications due to the im- and explantation of the balloon were observed.
The application of an intragastric balloon seems to be effective with regard of weight loss. The patient gets the chance to learn a more effective diet regimen which in our study population had a long lasting effect. Implantation of an intragastric balloon seems to be effective for a selective and highly motivated subpopulation of obese patients.
超重和极度病态肥胖是我们社会中的常见问题。目前有许多治疗选择,但没有一种可被视为理想选择。这些治疗干预措施之一是在内镜引导下植入胃内球囊。
研究胃内球囊植入对体重减轻的影响。
在一项前瞻性(部分为盲法)研究中,对4组患者(每组n = 10)进行了评估。第一组和第二组在内镜引导下植入胃内球囊。第二组接受了营养师的强化额外治疗。第一组被建议将饮食限制在1500千卡。第三组接受了假植入,并接受了与第二组相同的额外治疗。第四组作为对照组,除了被建议限制饮食外,未接受任何类型的治疗。所有球囊在6个月后取出。总体随访率为18个月,定期监测患者体重。
所有4组的患者纳入标准具有可比性。与第三组和第四组相比,第一组和第二组在6个月和12个月后体重显著减轻。这种体重减轻随时间稳定,18个月后达到统计学意义。此外,第二组(营养师强化额外治疗)的结果优于第一组。第四组患者体重增加。未观察到因球囊植入和取出导致的重大并发症。
胃内球囊的应用在减肥方面似乎是有效的。患者有机会学习更有效的饮食方案,在我们的研究人群中,这种方案具有长期效果。胃内球囊植入似乎对肥胖患者中一个有选择性且积极性高的亚群体有效。